Table 1.
Patient demographics, duration of organ support, and mean and peak amylase concentrations in survivors and non-survivors
|
All patients
(n = 234) |
Survivors
(n = 147) |
Non-survivors
(n = 87) |
|
|---|---|---|---|
| Age (years)* | 59 (51.0–64.3) | 56.0 (47.0–63.0) | 61.0 (57.0–66.0) |
| Men | 167 (71.4) | 101 (60.5) | 66 (39.5) |
| BMI (kg/m2)* | 27.7 (24.5–31.4) | 27.6 (24.8–32.7) | 27.6 (23.9–30.3) |
| Duration of ICU stay (days)* | 14.7 (6.0–31.1) | 16.0 (5.6–35.6) | 12.1 (6.0–20.0) |
| Duration of advanced respiratory support days (days)*† | 13.0 (4.0–25.3) | 13.0 (3.0–29.0) | 13.0 (6.0–2–.0) |
| Mean amylase (units/l)* | 90.3 (56.2–136.5) | 90.0 (56.3–132.9) | 90.5 (55.1–139.1) |
| Mean amylase > ULN (100 units/l) | 97 (41.5) | 63 (65) | 34 (35) |
| Peak amylase (units/l)* | 158 (82.8–274.5) | 157 (90.0–273.0) | 160 (79.0–330.0) |
| Peak amylase > 3 × ULN (300 units /l) | 52 (22.2) | 30 (58) | 22 (42) |
| Peak amylase > 2 × ULN (200 units/l) | 94 (40.2) | 58 (62) | 36 (38) |
| Peak amylase > ULN (100 units/l) | 158 (67.5) | 103 (65.2) | 55 (34.8) |
| Peak amylase ≤ ULN (100 units/l) | 76 (32.5) | 44 (57.9) | 32 (42.1) |
Values in parentheses are percentages unless indicated otherwise;
*
values are median (i.q.r.).
†
Mechanical ventilatory support via endotracheal tube. ULN, upper limit of normal.